For further details see:
FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancerFor further details see:
FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancerMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Genocea Biosciences Inc. Company Name:
GNCA Stock Symbol:
Market:
Genocea Biosciences Inc Ordinary Shares (GNCA) is expected to report for Q4 2022